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Abstract 
Cyanobacteria produce a variety of secondary metabolites of peptidic nature, many 
of which with potent biological activities. These can be produced either ribosomally or 
non- ribosomally. Cyanobactins are a group of recently described cyclic peptides with low 
molecular weight, synthesized by ribosomal pathways that exhibit important bioactivities, 
such as antitumor, cytotoxic or multi-drug-reversing activities.   
Anacyclamides are a set of cyclic cyanobactins, which have been described from 
strains belonging to the Anabaena genus. 
The main objective of this work was the detection of anacyclamide- related genes in 
cyanobacteria from the culture collection of LEGE (LEGE CC) in an attempt to expand the 
diversity of anacyclamides know to date. In addition, we tried to characterize the 
cyanobacterial strains using both morphological and molecular data, with the ultimate goal 
of making phylogenetic inferences regarding cyanobactins production.  
For this effect, we conducted a molecular screening among Anabaena strains, for a 
gene involved in the synthesis of the ribosomal peptides cyanobactins (patE). As a result, 
we detected a putative new anacyclamide in two of the ten Anabaena strains. Sequencing 
of the patE gene allowed us to predict the amino acid sequence of a new anacyclamide. 
The presence of the new compound in the cultures was checked using LC-MS, which 
additionally suggested that the cyanobactin was post-translationally modified through two 
prenylation events. 
By expanding the known genetic and chemical diversity of anacyclamides this work can 
help us to know more about the cyanobactins. In particular, this new anacyclamide can 
aid in investigations on post-translational processing of cyclic peptides derived from these 
pathways. 
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Resumo 
As cianobactérias produzem uma variedade de metabolitos secundários de natureza 
peptídica, muitos dos quais apresentam forte bioactividade. Estes biocompostos podem 
ser produzidos quer por via ribossomal quer por via não ribossomal. As cianobactinas são 
um grupo de péptidos cíclicos recentemente descobertos, com baixo peso molecular, 
sintetizados por ribossomas e que apresentam importantes bioactividades, tais como 
actividade citotóxica, anti tumoral ou reversora de multi drogas. 
Neste sentido, o objectivo principal deste trabalho foi a detecção dos genes relacionados 
com a produção de anaciclamidas em cianobactérias provenientes da colecção de 
culturas LEGE (LEGE CC), com a consequente identificação de novas anaciclamidas. Da 
mesma forma, foi feita a caracterização morfológica e o rastreio molecular das estirpes de 
cianobactérias, tendo como ultimo objectivo a análise filogenética, atendendo à produção 
de cianobactinas por parte das mesmas. 
Para este efeito, o rastreio molecular teve como alvo o gene envolvido na síntese dos 
péptidos ribossomais (cianobactinas) – patE. Como resultado, detectámos uma nova 
anaciclamida em duas das dez estirpes analisadas.  
A sequenciação do gene patE permitiu-nos prever a presença da anaciclamida, bem 
como a sua sequência de amino ácidos, em duas das dez estirpes em estudo. A 
presença desta nova anaciclamida nas culturas foi confirmada usando a LC-MS. A 
utilização desta técnica também demostrou que a nova cyanobactina apresentava 
modificações pós tradução bem como dois grupos -prenil na sua constituição. 
Assim, este trabalho ajudou a aumentar o conhecimento sobre este grupo de péptidos, de 
baixo peso molecular e com grandes variações estruturais. O estudo da nova 
anaciclamida pode estender-nos o conhecimento em relação às modificações pós 
tradução, que caracterizam estes péptidos, particularmente sobre prenilação. 
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1. Introduction 
Many aquatic organisms are able to produce bioactive secondary metabolites, some 
of which with the potential of being used in biotechnology (Arnison et al. 2013; Schmidt et 
al. 2005; Sivonen et al, 2010). Cyanobacteria are a particularly rich source of bioactive 
secondary metabolites (Sivonen et al., 2008). These include biomedically interesting 
compounds, such as the anticancer drug lead cryptophycin (Magarvey et al., 2006) and 
environmentally problematic hepatotoxic peptides, such as microcystins , nodularins and 
many other toxins produced by bloom-forming cyanobacteria (Sivonen et al.,2008). Many 
of these compounds are peptides containing nonproteinogenic amino acids, produced by 
nonribosomal peptide synthesis (Sivonen et al., 2008; Welker et al., 2006). Additionally, 
modified peptides produced by ribosomal pathways – cyanobactins - have recently been 
found in cyanobacteria (Donia et al., 2008; Donia and Schmidt, 2010; Leikoski et al., 
2009, 2010, Schmidt et al., 2005; Sivonen et al., 2010). This study was carried out within 
this topic and here we report a novel low-molecular-weight peptide produced ribosomally 
by Anabaena strains. 
1.2. Cyanobacteria 
Cyanobacteria are a phylum of oxygenic photosynthetic prokaryotes that have two 
photosystems (PSII and PSI) and use H2O as a photoreductant in photosynthesis. All 
known cyanobacteria are photoautotrophic, using primarily CO2 as the carbon source. 
(Castenholz, 2001). Many cyanobacterial species are also capable of atmospheric 
nitrogen fixation. 
Cyanobacteria have a gram-negative cell wall, which includes two distinct 
membranes, the plasma membrane and an outer membrane, and a peptidoglycan layer, 
which is thicker than in other Gram-negative bacteria, between these two membranes 
(Hoiczyk and Hansel 2000). External to the cell wall are different layers that protect the 
cells from desiccation and presumably from phages and predators. Cyanobacteria contain 
extensive internal thylakoid membranes, which are the site of photosynthetic reactions 
(Woese, 1987; Hoiczyk and Hansel, 2000; Liberton, 2011). 
These organisms are morphologically very diverse, with unicellular, colonial, and 
multicellular filamentous forms and can inhabit a wide range of environments including 
 2 
 
extreme conditions such as hot springs, the poles and, desert soils. Cyanobacterial 
species can occupy terrestrial habitats and, more commonly, aqueous environments 
(Sivonen et al., 2010). According to the botanical system of classification, cyanobacterial 
diversity has been traditionally grouped into five orders, Chroococcales, Pleurocapsales, 
Oscillatoriales, Nostocales and Stigonematales, which generally correspond to the five 
subsections proposed in the Bergey’s Manual of Systematic Bacteriology (Knoll, 2008; 
Whitton, 2008). Cyanobacteria form a distinct group in bacterial tree of life, based on 
bacterial 16S rRNA genes (Castenholz, 2001). They are responsible for the production of 
many toxins, including the most studied group of cyanobacterial secondary metabolites, 
the hepatotoxic microcystins (Sivonen and Jones, 1999). Cyanobacteria are also a rich 
source of other secondary metabolites, some of which have interesting antimicrobial, anti-
HIV, anti-malaria and anticancer activities (Burja et al., 2001, Welker and von Döhren 
2006, Linington et al., 2007). Of particular interest for the present work, we emphasize the 
cyanobactins group of secondary metabolites, which are a group of cyclic peptides 
recently found in cyanobacteria (Donia et al., 2008).  
1.2.1. Cyanobacteria toxic effects 
Some cyanobacteria frequently form mass occurrences (blooms) in aquatic systems 
(freshwater as well as marine environments). This phenomenon occurs under favorable 
environmental conditions, such as salinity, light, temperature and nutrient concentration 
and usually results in the release of the cells’ constituents (which sometimes includes 
potent toxins, termed cyanotoxins) to the water body (Béchemin et al., 1999; John and 
Flynn, 2000). At this level, eutrophication (natural or anthropogenic) and global warming 
have a strong influence in ecosystem health, but also in the economic development and in 
public heath, because the population is a consumer of aquatic resources that can be 
contaminated with cyanotoxins (John and Flynn, 2000; Paul, 2008). 
Studies on planktonic cyanobacteria from freshwaters and marine ecosystems 
became more common since the first report of a toxic episode caused by cyanobacteria in 
1878 (Francis, 1878; Sivonen and Jones, 1999). Eventually, the study of toxic compounds 
produced by cyanobacteria revealed the biotechnological potential of these organisms, in 
terms of their production of bioactive compounds. These biocompounds can be of 
different chemical families, including lipids, terpenes, glycosides, polyketides and peptides 
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or hybrids of some of these classes (Metting and Pyne, 1986, Rouhiainen et al., 2000; 
Tan et al., 2001, Donia et al., 2008, Donia and Schmidt, 2010). 
A significant fraction of these cyanobacterial compounds are linear and cyclic 
peptides that are produced by either ribosomal or nonribosomal biosynthetic pathways. 
The first, ribosomal pathway, was described in 2005 for the cyanobactin patellamide 
(Schmidt et al., 2005) while the first nonribosomal gene cluster had been reported earlier 
for the cyanotoxin microcystin (Tillet et al., 2000). Many cyanotoxins are partially or fully 
produced by nonribosomal pathways and released to the environment, such as 
microcystin; nodularin; saxitoxin and cylindrospermopsin. On the other hand, 
cyanobactins have been discovered as novel peptides produced ribosomally and their 
ecosystem-level impact is currently unknown (Schmidt et al., 2005; Arnison et al., 2013). 
1.3. Cyanobactins 
The cyanobactins are small peptides with low molecular weight, produced by 
various strains of free-living or symbiotic cyanobacteria, in terrestrial, marine or freshwater 
environments. (Schmidt et al., 2005; Donia et al., 2006; Sivonen., 2010). In this group are 
included compounds with anti-malarial, anti-tumoral and multidrug reversing action (Burja 
et al., 2001, Welker and von Döhren, 2006, Linington et al., 2007, Salvatella et al., 2003). 
Therefore, cyanobactins are compounds of potential interest to the pharmaceutical 
industry. These compounds possess versatile structures and are produced by proteolytic 
cleavage and cyclization of hypervariable peptide precursors, coupled with other post-
translational modifications such as heterociclization, prenylation of amino acid or oxidation 
(Sivonen et al., 2010; Leikoski et al., 2010). Cyanobactins are ribosomally synthesized 
and post-translationally modified peptides (RiPPs), which are produced by a pathway now 
designated as post-ribosomal peptide synthesis (PRPS) (Arnison et al., 2013). In PRPS, 
an unmodified precursor peptide produced by normal translation on the ribosome, 
includes the sequence that will correspond to the end-product peptide, termed core 
sequence (Oman and van der Donk, 2010 and Arnison et al., 2013).Subsequently, the 
precursor peptide is cleaved and modified to form the final product (Figure1). 
The cyanobactin gene cluster usually encodes two proteases responsible for the 
cyclization and cleavage of the precursor peptide (Sivonen et al., 2010). 
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Figure 1- Schematic of post-ribosomal peptide synthesis (PRPS) (Adapted from Arniston et 
al., 2013 and Leikoski et al., 2013) 
Initially, cyanobactins were proposed as a group of cyclic peptides containing 
oxazolines, thiazolines, or their oxidized derivatives oxazoles and thiazoles (Sivonen et 
al., 2010). This definition was modified to include cyclic peptides which consist solely in 
proteinogenic amino acids (Leikoski et al., 2010). Sometimes, isoprenoid amino acids 
derivatives are also found, for example in trunkamide, patellin, and anacyclamides, 
although they are rare (Sivonen et al., 2010). Hence, cyanobactin was proposed as a 
collective name for cyclic peptides which can contain heterocyclized amino acids or 
isoprenoid amino acid derivatives (Donia et al., 2008; Schmidt and Donia, 2009). Very 
recently it has been shown that some cyanobacteria produce short linear cyanobactins 
with a chain length ranging from three to five amino acids (Leikoski et al., 2013). 
According with the Leikoski et al. (2013) study, these linear cyanobactins were N-
prenylated and O-methylated on N and C termini, respectively. 
1.3.1. Analogous pathways 
Similarly to cyanobactins, another cyanobacterial peptide class, microviridins, was 
recently shown to be ribosomally produced in Microcystis aeruginosa and Planktothrix 
agardhii, but their biosynthetic machinery differs that of cyanobactins (Ziemert et al., 
2008a; Philmus et al., 2008; Sivonen et al., 2010). Initially, these compounds were 
thought to be products of nonribosomal peptide biosynthesis. However, microviridins are 
synthesized from precursor peptides that are converted into tricyclic depsipeptides 
through the action of ATP grasp ligases and a transporter peptidase (Ziemert et al., 
2008a; Philmus et al., 2008). The work of Philmus et al. (2008) reported similar gene 
clusters in the genomes of Anabaena variabilis, Nostoc punctiforme, and Nodularia 
Translation of the precursor gene
Core peptide
NH2 - - COOH
Post-translational modifications 
by the modifying enzymes
Percursor peptide
SRiPP
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spumigena as well as in genomes of other bacteria. The biosynthetic gene clusters 
encoding the production pathway of ribosomal peptides with oxazoles and thiazoles are 
present in a broad range of bacteria (Lee et al., 2008). Bacteria distantly related to 
cyanobacteria are known to produce bacteriocins by posttranslational modification. 
Cyanobactin biosynthesis is analogous in many ways to the biosynthesis of bacteriocins 
(Franz et al., 2007; Nolan and Walsh, 2009). The leader-peptide-guided biosynthesis is 
common in many ribosomally synthesized natural products where the precursor peptide is 
synthesized and cleaved, and in some cases the core peptide is posttranslationally 
modified (Oman and van der Donk, 2010). Bacteriocins can also present cyclization as 
cyanobactins, and also similar posttranslational modifications for example in case of 
thiazoles and oxazoles (Jack and Jung, 2000; Maqueda et al., 2008; Martin-Visscher et 
al., 2009). 
Many of cyanobacterial bioactive compound classes are synthesized on 
nonribosomal peptide synthetases (NRPS) or combined NRPS and polyketide synthases 
(Welker and von Döhren, 2006; Sivonen and Börner, 2008). However, the cyanobactins 
have been shown to be produced by posttranslational modification of the gene-encoded 
precursor peptides (e.g., Schmidt et al., 2005; Donia et al., 2008). The gene clusters 
responsible for ribosomal peptide production are small compared to the large 
nonribosomal peptide synthetase gene clusters. In NRPS, variation in the chemical 
structure of the peptide is achieved by utilization of more than 200 nonproteinogenic 
amino acids (Nolan and Walsh, 2009) whereas ribosomal peptides are restricted to 20 
proteinogenic amino acids which may be posttranslationally modified. In NRPS, the 
enzymes seem to have relaxed substrate specificity and thus allow simultaneous 
production of a number of structural variants in the same strain of a cyanobacterium 
(Welker and von Döhren, 2006). 
1.3.2. Chemical diversity and Occurrence 
A large part of cyanobactins, more than hundred as suggested by Sivonen et al. 
(2010) and Donia et al. (2008), have been identified from symbiotic associations formed 
between cyanobacteria and ascidians or from free-living cyanobacteria. This renders 
cyanobactins one of the largest classes of cyanobacterial peptides produced (Donia et al., 
2006; Schmidt and Donia, 2009). In general, cyanobactins produced by ascidians and 
sponges, for example, usually contain from six to ten amino acids and varying numbers 
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and combinations of oxazoles, oxazolines, thiazoles, and thiazolines (Sivonen et al., 
2010). A few cyanobactins, such as ulithiacyclamides, containing prenylated amino acids, 
have disulfide bridges between two cysteine residues. It is unclear if the cyanobactins are 
produced by the filter feeding organisms themselves, heterotrophic bacteria, or 
cyanobacteria associated with these organisms, but some cyanobactins have now been 
shown to be produced by cyanobacteria (Schmidt et al., 2005; Donia et al., 2006; Sivonen 
et al., 2010). For the majority of the analogous cyclic peptides reported from 
cyanobacteria, a biosynthetic origin is currently unknown. Hitherto, only ribosomal 
biosynthetic pathways have been described to produce these cyclic peptides (Schmidt et 
al., 2005; Donia et al., 2006, 2008; Sudek et al., 2006; Ziemert et al., 2008b; Leikoski et 
al., 2010). Still, a nonribosomal peptide synthetase pathway could be an alternative route 
for the biosynthesis of these compounds (Sivonen et al., 2010). In general, cyanobactins 
that contain heterocyclized amino acids range in size from six to eleven amino acids. 
Cyanobactins without heterocyclized amino acids have a length from seven to twenty 
amino acids. An interesting fact is that cyanobactins without heterocyclized amino acids, 
in addition to occasional prenylations, can present a conserved proline residue. Oxazoles 
and thiazoles are more common, while oxazolines or thiazolines occur with a lower 
frequency (Sivonen et al., 2010). 
 
 
 
 
 
 
 
 
 
 
Trunkamide 
Tenuecyclamide C 
Ulithiacyclamide 
Anacyclamide A10 
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1.3.3. Biosynthesis of cyanobactins  
Cyanobactins are made through PRPS (Arnison et al., 2013). It means that a gene-
encoded precursor peptide is first transcribed. The precursor peptide is 50-150 amino 
acids long and the final peptide is modified and cleaved (Donia and Schmidt, 2010; 
Sivonen et al., 2010). The cleavage of the cyanobactin precursor peptide takes place at a 
minimum of two sites. In adition to the cleavage, the cyanobactin precursor is N-to-C 
macrocyclized and some amino acids can be modified (Donia and Schmidt, 2010; Oman 
and van der Donk, 2010; Sivonen et al., 2010). A hypervariable amino acids core 
sequence inside these will ultimately form the cyanobactin (Figure 3) (Donia et al., 2006, 
Patellamide A 
Trichamide 
Viridisamide A 
Figure 2- The chemical structures of a selection of cyanobactins. Trunkamide was isolated 
from L. patella, tenuecyclamide from N. spongiaeforme, anacyclamide from Anabaena, 
trichamide from T. erythraeum, ulithiacyclamide and patellamide from Prochloron( 
Originally from L. Patella); Viridisamide from Oscillatoria viridis PCC7112.(Adapted from 
Sivonen el al., 2010 and Leikoski et al., 2013). The post-translational modifications; 
oxazoline, thiazole, and reverse O-prenyl are highlighted with circles. In the linear 
cyanobactin, the identical prenylated N-termini and methylated C-termini bound to 
thiazoles are in blue. (Adapted from Sivonen et al., 2010; Leikoski et al., 2013) 
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Donia et al., 2008). Commonly, the cysteines, threonines and serines are heterocyclized 
to thiazolines and oxazolines, which can be oxidized to thiazoles and oxazoles (Figure 2). 
The core sequence may also be prenylated (Donia et al., 2008; Donia and Schmidt, 
2011). 
Thus, cyanobactins results from the proteolytic cleavage and head-to-tail (N–C) 
cyclization of precursor peptides coupled with modification of specific amino acids. 
(Sivonen et al.,2010; Oman and van der Donk, 2010). This cyclic structure results from 
the amide linkage of the α-carbonyl of C-terminal amino acid and α-amino group of the N-
terminal amino acid.  
In cyanobactins biosynthesis, the precursor peptide, designated with the letter “E”, 
directly encodes one or more cyanobactins flanked by the putative recognition sequences 
at which the precursor peptide is cleaved by two proteases, A and G (Schmidt et al., 2005; 
Lee et al., 2009; Donia and Schmidt, 2010; Sivonen et al., 2010). The fact that the 
precursor peptide can encode more than one cyanobactin represents a mechanism to 
generate chemical diversity in peptide production.  
The cyanobactin gene cluster is approximately 10 kb (contained between 7 and 12 
genes) and consists of the genes A into G, however the gene arrangement can vary.  This 
gene cluster encodes two proteases (A and G), which are involved in the cleavage of the 
precursor peptide and cyclization of cyanobactin (Lee et al., 2009; Sivonen et al., 2010). 
In the biosynthetic gene cluster of patellamide it was shown that the encoded PatA 
proteases is responsible for cleavage the precursor peptide at the N-terminal recognition 
sequence while the PatG protease cleaved the precursor peptide at the C-terminal 
recognition sequence (Lee et al., 2009). However, only the G- protease has a 
macrocyclase domain which N-to-C cyclizes the cyanobactin (Lee et al., 2009). As stated 
above, the gene order is not strictly conserved but generally biosynthetic genes are 
organized as in the patellamide pat gene cluster (Figure 4). All of the cyanobactin gene 
clusters contain two the two tandem-acting proteases, a short precursor peptide as well as 
proteins involved in the maturation of the cyanobactins (Sivonen et al., 2010). Thiazoles 
and oxazoles are formed through the heterocyclization and subsequent oxidation of 
cysteine, serine, and threonine amino acids. In general, cyanobactin gene clusters contain 
a gene encoding a PatD homolog which is predicted to heterocyclize cysteine, serine, and 
threonine to thiazolines and oxazolines (Schmidt et al., 2005). The oxidase domain of the 
bimodular PatG protein is believed to catalyze the oxidation of thiazolines and oxazolines 
to thiazoles and oxazoles (Schmidt et al., 2005). A PatF homolog is often encoded in 
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cyanobactin gene clusters and thought to be involved in the heterocyclization and/or 
prenylation of cyanobactins (Schmidt and Donia, 2009). In general, the PatB and PatC 
proteins are encoded in the majority of cyanobactin gene clusters but were found to be 
nonessential - in Escherichia coli the patellamides were produced by heterologous 
expression of the pat gene cluster, even in the absence of the patB and patC genes 
(Figure 3). 
 
Figure 3- Schematic figure of the cyanobactin gene cluster (homologous to the pat gene 
cluster
1
) and the structure of the precursor peptide (E). The functions of the genes are 
shown. The genes B and C are of unknown function. The cyanobactin structures are formed 
from the core region shown in the precursor peptide. (Adapted from Houssen el al., 2012; 
1
 
Donia et al., 2008; 
1
Schmidt et al., 2005) 
The biosynthetic genes for cyanobactin production have been described in distantly 
related cyanobacteria Prochloron, Trichodesmium, Microcystis, Prochlorococcus, 
Synechococcus, Nostoc, Lyngbya, and Anabaena (Figure 4) (Schmidt et al., 2005; Donia 
et al., 2006, 2008; Sudek et al., 2006; Ziemert et al., 2008b; Leikoski et al., 2010; Shih et 
al., 2013). One of the protease genes responsible for cleavage of the cyanobactin 
precursor peptide was shown to be common among planktonic freshwater cyanobacteria 
and present in 48 out of 132 strains studied (Leikoski et al., 2009; Sivonen et al., 2010). 
These planktonic cyanobacteria included fresh and brackish water strains from 
filamentous heterocystous (Anabaena, Aphanizomenon, Nodularia), filamentous 
(Planktothrix), as well as colony-forming (Microcystis and Snowella) cyanobacteria. The 
biosynthetic pathway appears to be relatively common among these strains (Leikoski et 
al., 2009). 
A B C D E F G
N-terminal protease Heterocyclase Prenyltransferase
C-terminal protease, 
macrocyclase (oxidase)
N- terminal 
cleavage
C- terminal 
cleavage
Percursor peptide (E) core core
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Figure 4- Cyanobactin gene clusters published from seven distantly related cyanobacteria. 
These gene clusters are typified by genes encoding proteases (yellow), a short precursor 
peptide (red), proteins involved in the maturation of the cyanobactin (black), as well as 
conserved and hypothetical open reading frames (white). (Adapted from Sivonen et al., 
2010) 
1.3.4. Bioactivities 
Cyanobactins and cyclic peptides with analogous structures have diverse reported 
bioactivities. This diversity is derived from their variable structures. However, until this 
moment, this bioactivity has not been studied systematically for the cyanobactins. 
A large fraction of cyanobacterial metabolites have been found to be anticancer 
compound. For example, trunkamide (Salvatella et al., 2003) has multidrug reversing 
(Ogino et al.,1996) as well as anti-viral activities (Burja et al., 2001, Welker and von 
Döhren, 2006, Linington et al., 2007) or acting against tropical parasites such as 
Plasmodium falciparum (Linington et al., 2007; Portmann et al., 2008b).  
According to Nolan and Walsh (2009), in Bacteria many of the ribosomally produced 
peptides are antibiotics or bactericides are produced to kill or inhibit growth of competing 
microbes. Some compounds that were isolated from cyanobacteria present antibiotic 
(Ishida et al., 1997) or antiviral (Boyd et al., 1997; Bokesch et al., 2003) effects; hence, a 
strong possibility is that cyanobactins are defense molecules.  
patA patB patC patD patE patF patG
mcaA mcaB mcaC mcaD mcaE mcaF mcaG
tenA tenB tenC tenD tenE tenF tenG
truA truB truC truD truE truF1 truF2 truG
lynA lynB lynC lynD lynE lynF lynG
acyC acyB acyA acyE acyF acyG
triEtriA triB triC triD triF triG triH triI triK
Prochloron spp.
(patellamide)
Microcystis aeruginosa
(microcyclamide)
Nostoc spongiaeforme
(teneucyclamide)
Prochloron
(patellin, trunkamide)
Lyngbya aestuarii
(Lyngbyabactin)
Anabaena sp.
(anacyclamide)
Trichodesmium erythraeum
(trichamide)
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1.4. Anacyclamides 
Anacyclamides are a group of cyanobactins with alike structural features. Leikosky 
et al. (2010) identified several anacyclamides from strains of genus Anabaena. This study 
revealed the acy gene cluster in Anabaena sp. 90, which encodes 11 open reading frame 
(ORFs), and is arranged in an 11kb operon which is bidirectionally transcribed ( Sivonen 
et al., 2010). The acy gene cluster shows a limited degree of homology with the pat gene 
cluster. Some hypothetical ORFs present in the acy gene cluster were also absent in the 
pat gene cluster (Leikoski et al., 2010). The precursor peptide AcyE encodes a single 
copy of the cyanobactin anacyclamide A10- flanked by putative recognition sequences 
which differ substantially from other cyanobactin precursors. The anacyclamide gene 
cluster lacks a PatD-homolog in conformity with the anacyclamides lack of 
posttranslationally heterocyclized amino acids (Leikoski et al., 2010). Likewise, the AcyG 
protein also lacks an oxidase domain (Leikoski et al., 2010). 
The length of the anacyclamides is highly variable, as is the amino acid sequence, 
with only one proline being conserved (Sivonen et al., 2010). 
 
Figure 5- Arquitecture of the anacyclamide gene cluster (Houssen el al., 2012). 
 
Mature cyanobactin
acyE gene
acyC acyB acyA acyE acyF acyG
1kb
 12 
 
1.5. Anabaena 
The nostocalean genus Anabaena includes filamentous, heterocyst-forming 
cyanobacteria that can have gas vacuoles (Rippka et al., 2001). The presence of 
heterocysts in Anabaena coupled with a fast growth rate has rendered Anabaena one of 
the most studied cyanobacterial genera. Heterocysts are specialized nitrogen-fixing cells 
formed during nitrogen starvation by some filamentous cyanobacteria of the orders 
Nostocales and Stignomatales. These cells fix nitrogen from dinitrogen (N2) in the air 
using the enzyme nitrogenase, which is then used in the cells for biosynthesis. 
Nitrogenase is inactivated by oxygen, so the heterocyst must create a microanaerobic 
environment. An additional envelope surrounds heterocysts, helping to protect the 
enzyme nitrogenase from oxygen (Fay, 1992). Heterocysts are typically distinguishable 
from vegetative cells due to their somewhat larger and rounder shape, diminished 
pigmentation, thicker cell envelopes, and usually prominent cyanophycin granules at poles 
adjacent to vegetative cells (Figure 6). Mature heterocysts provide the ideal environment 
required for nitrogen fixation, especially separating the oxygenic photosynthesis in 
vegetative cells (Golden and Yoon., 1998) 
  
Figure 6- Heterocysts development (1) in Anabaena LEGE 00259, one of the strains used in 
this work. 
Anabaena sp. can produce neurotoxic and cytotoxic alkaloids and hepatotoxic cyclic 
peptides (Sivonen and Jones, 1999). This variety of toxins has a strong impact on 
ecosystems and, consequently, several actions on terrestrial vertebrates, especially 
mammals. Some examples of saxitoxin and cylindrospermopsin from Anabaena have 
been reported (Sivonen and Jones, 1999). Microcystin is one of the most frequently 
cyanobacterial toxins found in Anabaena blooms and act as an inhibitor of protein 
phosphatase. Similarly, anatoxin-a and anatoxin-a(S) have been characterized from this 
genus and their mechanism of action is binding irreversibly to the nicotinic acetylcholine 
receptors and the inhibition of acetylholinesterase activity, respectively.  
1 
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This study was carried out using only Anabaena strains. 
1.6. Biotechnological Aspects  
The biotechnological exploitation of cyanobactins will require detailed studies on the 
enzymes involved in the biosynthesis as well as mechanisms of action of these peptides.  
The small size of the cyanobactin gene clusters and their amenability to be fully 
heterologously expressed (Schmidt et al., 2005; Donia et al., 2006, 2008; Leikoski et al.,  
2010) will provide new possibilities to create compound libraries and novel compounds 
(Donia et al., 2006, 2008). In the study of cyanobactins pathway, the heterologous 
expression gives options to study the role of individual genes in biosynthesis as well as 
produce novel peptides. The core sequence of the precursor peptide directly encodes the 
resulting cyanobactin and this sequence can be changed easily by genetic engineering in 
heterologous hosts and recombinant peptides can be produced (Donia et al., 2006; 
Tianero et al., 2012).  
According to Donia et al. (2006) the cyanobactin pathway was utilized in E.coli to 
synthesize an engineered cyclic peptide (eptidemnamide) similar to an anticoagulant in 
clinical use. This approach demonstrates a means to exploit cyanobacterial pathways and 
produce novel compounds by the rational design of peptides (Donia et al., 2006; Sivonen 
et al., 2010). 
According to the work by Oman and van der Donk (2010) the peptide precursor-
directed synthesis allows manipulations directly to the precursor gene and enables 
production of engineered peptides in heterologous hosts. In addition, the enzymes in the 
cyanobactin pathways could be used as catalysts to assist the chemical synthesis of the 
desired compounds. 
The work by Lee et al. (2009), showcased not only the important role of proteases in 
cyanobactin biosynthesis but also was demonstrated the potential of the enzymes as 
general catalysts for cyclization of peptides. The PatG protease was shown to require no 
exogenous energy for the cleavage and cyclization, and to be tolerant to different 
substrate lengths and sequences as long as the C-terminal recognition sequence was 
present (Sivonen et al., 2010; Lee et al., 2009). This is important, for example, in synthetic 
peptide manufacture where the head-to-tail cyclization restricts peptide production in bulk 
amounts (Sivonen et al., 2010). It is important to note that whole-genome information has 
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already led to the discovery of cyanobactin biosynthesis as well as several new 
compounds and compound classes, for example novel patellamides (Schmidt et al., 
2005), trichamide (Sudek et al., 2006), and anacyclamides (Leikoski et al., 2010).  
The number of genome sequencing projects involving cyanobacteria and 
metagenomic studies applied to various environments is increasing. This should allow 
new discoveries in the near future, including new ribosomal pathways and cyanobactins. 
1.7. Objective 
The main objectives of this work were the detection of anacyclamide- related genes 
in cyanobacteria from the culture collection LEGE (LEGE CC) and, the corresponding 
identification of new anacyclamides. As a secondary objective, we tried to characterize the 
cyanobacterial strains using both morphological and molecular data, with the ultimate goal 
of making phylogenetic inferences regarding cyanobactins production.  
For this purpose, a PCR-screening of ten freshwater cyanobacterial strains for 
cyanobactin-related genes was carried out. The resulting amplicons were then cloned and 
sequenced in order to identify potential producers of new members of this class of 
compounds. Finally, investigations on the production and the nature of the new 
cyanobactins were performed using analytical methodologies.  
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2. Material and Methods 
The methods used are outlined in the workflow shown in figure 7.  
 
Figure 7- Schematic drawing of the workflow. 
2.1. Source of strains 
Cyanobacteria used in this study are part of the LEGE culture collection and had 
been isolated from water samples collected from freshwater supplies, located in north and 
central regions of Portugal (Table1). Additionally, for comparison purposes, the strain 
Anabaena sp.90, isolated in Finland from Lake Vesijärvi, in 1986 and maintained at the 
University of Helsinki was used (Sivonen et al., 1992). 
 
1Cyanobacteria strains
(10 Anabaena strains)
2Culture growth
3gDNA extraction, screening of 
16S rRNA gene and anacyclamide
related- genes by PCR 
5Screening anacyclamides by 
LCMS based on the presence 
of a prenyl unit
3Cloning and sequencing 
of the precursors genes
Predictions of 
anacyclamides structures
Putative anacyclamide
5LCMS- detection and 
characterization of the 
predicted anacyclamide
Hight accuracy UPLC-ESI-
QTOF
 16 
 
Table 1- Identification of the ten strains in study, from the LEGE culture collection 
Anabaena 
strain 
Origin/source Isolator 
Year of 
harvest 
Co- 
identification 
LEGE00233 Maranhão reservoir 
Joana 
Osswald 
2000 J1 
LEGE00241 Maranhão reservoir 
Joana 
Osswald 
2000 J14 
LEGE00243 Maranhão reservoir 
Joana 
Osswald 
2000 J16 
LEGE00245 Maranhão reservoir 
Joana 
Osswald 
2000 J18 
LEGE00246 Maranhão reservoir 
Joana 
Osswald 
2000 J19 
LEGE00248 Maranhão reservoir 
Joana 
Osswald 
2000 J21 
LEGE00250 Maranhão reservoir 
Joana 
Osswald 
2000 J27 
LEGE00253 Chaves reservoir 
Joana 
Osswald 
2000 J37 
LEGE00259 Maranhão reservoir 
Joana 
Osswald 
2000 J46 
LEGE04289 
Marco de 
Canaveses 
Joana 
Osswald 
2004 J83 
2.2. Cyanobacterial strains and culturing 
The ten Anabaena sp. strains were grown in sterile Z8 medium (Kotai, 1972), in 40-
ml cultures under a 14:10 h light: dark cycle (Martins et al., 2005), with a photon irradiance 
of 10-30 µmol m2 s-1 at 25°C. 
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 Regarding large scale biomass production, for the chemical analyses, two isolates 
were grown in sterile 16L culture vessels, with aeration,  under 14:10h light: dark cycle, 
with a photon irradiance of 10-30 µmol m2 s-1 at 25°C. 
 
Figure 8- Cyanobacterial strains and Culturing 
Anabaena sp. Strains were grown in z8 medium, with aeration, under 14:10 light:dark at 25°C. 
2.3. DNA extraction, PCR amplification, Cloning and 
sequencing 
Genomic DNA (gDNA) extraction was carried out either with the Purelink genomic 
DNA mini kit (Invitrogen) or with the Dneasy Plant Mini kit (Qiagen). PCR amplification of 
the 16S small ribosomal subunit gene (16S rRNA gene) was carried out using the gDNAs 
as templates. Primers 27F, 359F and 1491R (Neilan et al., 1997; Jungblut et al., 2005), 
targeting the 16S rRNA gene, were used. 
 All PCR reactions were prepared in a 20µl of volume containing 10x PCR buffer for 
Super Taq (HT Biotechnology Ltd.). PCR conditions were as described previously. 
Amplicons were cloned into a PGEM-T vector and transformed into Oneshot E.coli TOP10 
cells (Invitrogen). Plasmid DNA was isolated from the transformed cells using the 
GenElute Plasmid MiniPrep kit (Sigma-Aldrich) and sequenced (Macrogen) using M13 
primers.  
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Table 2- Primers used for the 16S rRNA gene amplification.  
Primera Sequence (5’»3’) Reference 
27F AGAGTTTGATCCTGGCTCAG Neilan et al., 1997 
Jungblut et al., 2005 1494R TACGGCTACCTTGTTACGAC 
CYA359F GGGGAATYTTCCGCAATGGG 
a
Gene primers are named according to their locus 
The amplification of the patA gene was made using a pair of primers that amplified a 
1.4 kb section, PatAR and PatA F (Lee et al., 2009). These amplifications, using these 
primers, was already made by Leikoski et al. in previous studies to screen many 
cyanobactia strains, including Anabaena sp.90. The annealing temperature used in the 
PCR program was of 52°C.  
Anabaena sp.90 (Sivonen et al., 1992) was used as a positive control in the 
screening. 
In order to identify an Anabaena strain producing an anacyclamide, the acyE 
peptide precursor gene was ampliﬁed using primers preRNAF (5’-
GAAGAACATCCGCCCCCAACAAGTTG-3’) and preRNAR (5’-CTCCGCGTCGTC 
GCCTGCAAAAGG-3’) and primers PreF (5’-GCCTTCACCAAACCAGTCT TCTTCAT-3’) 
and PreR (5’-CATCGAGGCGAACCGTGCGCCAAGGGAT- 3’) (Leikoski et al., 2009) from 
the genomic DNA of all the Anabaena strains. The expected size band, for the last primer 
pair is about 312 pb and for the PCR program the Annealing Temperature was calculated 
at 53°C; using the first primer pair the expected size band is about 160 bp and the 
Annealing Temperature was calculated at 56°C. Following cloning and sequencing as 
described above, the amplified fragments were compared to those of known acyE 
precursor to infer the novelty of the encoded anacyclamide.  
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Figure 9- The acyE peptide precursor gene with the protease cleaving sites highlighted and 
the primer annealing regions shown. 
 
Table 3- PCR reaction for each primers pair 
Pair of primers 
PCR reaction 
a
 
Inicial 
Denaturation 
Denaturation Annealing  extension Final 
extension 
 
27F/1494R 
359F/1494R 
94°C 
4min 
35 cycles 72°C 
8min 
8°C 
∞ 94°C 
45sec 
50°C 
45sec 
72°C 
1min20sec 
preRNAF/preRNAR 
94°C 
2min 
94°C 
30sec 
56°C 
30sec 
72°C 
10sec 
72°C 
7min 
8°C 
∞ 
PreF/PreR 
94°C 
2min 
94°C 
30sec 
53°C 
30sec 
72°C 
20sec 
72°C 
7min 
8°C 
∞ 
a
The PCR reactions were calculated according with the specific primers used and they are not publish.  
2.4. Cloning the acy biosynthetic gene cluster  
In order to amplify the entire 12 kb gene cluster from genomic DNA of Anabaena sp. 
LEGE 00259 by PCR , the patex2f (5’-ATGGATCCTGATGGACTGTAGTGTGAG-3’) and 
patex5r (5’- TACTCGAGAGGTTTTGGGACTCTTTAG-3’) primer pair (Leikoski et al., 
Primers 
Leader
acyE gene percursor
5’ 3’
CoreNH2 COOH
Proteases
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2009) was used, in three 60-µL reaction mixtures, containing 10× PCR buffer for Super 
Taq Plus (HT Biotechnology Ltd.), 200 µmol of each nucleotide (Finnzymes), 0.75 µM of 
each primer, 0.8 U Super Taq Plus proofreading polymerase (HT Biotechnology Ltd.), and 
100 ng of Anabaena sp. LEGE 00259 gDNA. The thermocycling conditions were 94°C for 
2 min, followed by 30 cycles of 94°C for 30 s, 56.4°C for 30 s, and 68°C for 9 min and 
then a ﬁnal extension at 68°C for 20 min. The PCR products were separated on a 0.7% 
agarose gel containing 0.5× Tris-acetate-EDTA and run for 30 min at 100 V. The gel was 
stained using SYBR Safe DNA gel stain (Invitrogen) and was visualized using a Dark 
reader (Clare Chemical Research Inc.) to avoid DNA damage from UV light during gel 
extraction. The 12-kb PCR product was gel extracted with a MinElute gel extraction kit 
(Qiagen) and cloned into the PCR 2.1-TOPO vector using a TOPO TA cloning kit 
(Invitrogen) with an insert-to-vector molar ratio of 3:1. The vector was used to transform 
chemically competent E.coli One Shot TOP10 cells according to the manufacturer’s 
instructions. The resultant RC_c1, RC_c2 and RC_c3 plasmids were analyzed by PCR 
and restriction digestion to ensure that the integrity of the insert was maintained during the 
cloning and ampliﬁcation in E. coli. The transformants containing the 12-kb insert in the 
plasmid were grown overnight with shaking at 120 rpm at 28°C in 50 ml of LB medium 
containing 150 µg ml -1 of ampicillin (sodium salt; Sigma-Aldrich) for liquid chromatography 
(LC)-mass spectrometry (MS) analysis. The cells were harvested by centrifugation at 
10,000 × g for 10 min (Ep- pendorf 5804R centrifuge),  dried with a Heto vacuum 
centrifuge (Heto- Holten A/S), which yielded ca. 43 mg (dry weight) and sent to 
sequencing (Macrogen; Seoul, Korea). 
2.5. Biomass collection of LEGE 00248 and LEGE 00259 
and preparation of extracts  
The biomass of 16L cultures of LEGE 00248 and LEGE 00259 was collected following 
approximately one month of growth under the conditions detailed in the “Cyanobacterial 
strains and cultivation” section. The collection was carried out by filtration using a 41 µm 
plankton net. The filtered cells were then centrifuged at 4600rpm for 10min and the pellet 
was frozen and freeze-dried. 
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Figure 10- Biomass collection of 16L cultures of LEGE 00248 and LEGE 00259 strains 
2.5.1. Biomass extraction 
The lyophilized biomass was weighed and then methanol extraction was made 
(Leikoski et al., 2010) using 60ml of solvent (ACS grade). The biomass with methanol was 
macerated and then the supernatant was transferred into a 45ml falcon and centrifuged at 
4600×g for 10min. This procedure was repeated six times. The pooled supernatants were 
then concentrated in vacuo and the mass of the resulting crude extract determined. 
2.6. Chemical analysis 
Cells of Anabaena strains were collected from the 40 mL cultures by centrifugation at 
7,000 g for 7 min. The collected cells were freeze-dried with Supermodulyo (Edwards 
High Vacuum International) or dried with a Heto vacuum centrifuge, which yielded 5 to 12 
mg (dry weight). The dried Anabaena cells, as well as E. coli transformants, were 
extracted with 1 mL of methanol (HiperSolv, HPLC grade; BDH Laboratory Supplies) in 2 
mL plastic tubes containing glass beads (cell disruption medium; 0.5-mm-diameter glass 
beads; Scientific Industries Inc.). 
Each mixture was homogenized by shaking with a FastPrep cell disrupter (Bio 101, 
Thermo Electron Corporation, Qbiogene, Inc.) for 30 s at a speed of 5 ms-1. The mixture 
was centrifuged at 10000 x g for 5 min, and the supernatant was used for LC-MS analysis. 
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The methanol extracts were analyzed with a high-performance liquid chromatograph 
combined with a mass spectrometer (Agilent 1100 series LC/MSD with Ion Trap XCT Plus 
and an electrospray ion source) in order to detect low-molecular-weight peptides. 
Peptides were separated from the extracts by HPLC using a Phenomenex C18(2) column 
(2.0 mm x 150 mm; particle size, 5µm). The mobile phase gradient consisted of 0.1% 
aqueous (water purified with Milli-Q Plus; Millipore) formic acid (Fluka) (solvent A) and 
0.1% formic acid in isopropyl alcohol (Sigma-Aldrich) (solvent B). Two different settings 
were used; one setting was used for screening methanolic extracts of Anabaena cells, 
and the other setting (values in parentheses below) was used for further structural 
characterization of natural and synthetic peptides. The percentage of solvent B was 
increased from 5 to 50% in 60 min. A flow rate of 0.15 mL min-1 was used, and the 
columns were heated to 40°C during separation. The positive-ion mode of electrospray 
ionization was used. The pressure of the nebulizer gas (N2) was 30 lb/in
2 (35 lb/in2), the 
drying gas flow rate was 8 L min-1, and the temperature was 350°C. The capillary voltage 
was set at 5,000 V (4,500 V), and the capillary offset value was 300 V. A skimmer 
potential of 85 V (100 V) and a trap drive value of 144 (111) were used. Spectra were 
recorded using a scan range from m/z 100 to m/z 2200. Identification of the 
anacyclamides was based on the molecular weights calculated from the predicted peptide 
AcyE precursor amino acid sequences and the assigned fragment ion patterns of MSn (n= 
1 to 3) spectra. A comparison with the retention time and MS data for a synthetic 
reference was used in five cases (Beijing SBS Genetech Co., Ltd., China; anacyclamide 
B7 from JPT Peptide Technologies GmbH, Germany). 
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3. Results and Discussion 
In this study we proposed to detect new cyanobactins among ten Anabaena strains 
from LEGE CC. At the same time, it was our aim to characterize the cyanobacterial strains 
using both morphological and molecular data, with the final goal making phylogenetic 
inferences. For this purpose were made a variety of procedures, including genomic DNA 
extraction, PCR screening, in silico analysis and detection by LC-MS. 
3.1. Morphological characterization 
In the beginning of this work a morphological characterization was made for each 
strain. Microphotographs for each strain are shown in Figure 11. Morphometric 
parameters determined for each strain are presented in Table 4.  
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Figure 11- Morphological characterization of the Anabaena strains, using an optical 
microscopy approach. 1- LEGE 00233, 2- LEGE 00241, 3- LEGE 00243, 4- LEGE 00245, 5- 
LEGE 00246, 6- LEGE 00248, 7- LEGE 00250, 8- LEGE 00253, 9-LEGE 00259, 10- 04289. 
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3.1.1. Morphometry 
Table 4- Morphometric parameters for each strain 
Strains  Average cell length  (S.D) Average cell width (S.D) 
LEGE 00233 
 
4,84 (±0,84) 3,37 (± 1,20) 
LEGE 00241 
 
6,99 (±2,62) 3,91 (±0,35) 
LEGE 00243 
 
2,82 (±0,44  
LEGE 00245 
 
4,98 (±1,01) 4,43 (±0,57) 
LEGE 00246 
 
5,85 (±0.80) 2,82 (±0,36) 
LEGE 00248 
 
7,21(± 1,67) 2,89 (±0,33) 
LEGE 00250 
 
7,55 (±1,22) 2,00 (±0,39) 
LEGE 00253 
 
7,31 (±2,59)  
LEGE 00259 
 
6,97 (±1,15) 3,52 (±0,57) 
LEGE 04289 
 
7,27 (±1,97) 7,60 (±0,90) 
In accordance with the figure 11, which showed the microphotographs for each 
strain, we conclude that the morphological data obtained is consistent with the 
characteristics of  nostocalean  genus Anabaena, since that the main part of them 
presented filamentous morphology with heterocysts. The exception was the strain LEGE 
00243, which presented non-filamentous morphology.  
To support this characterization, the morphometric parameters determined for each 
strains was presented in Table 4. 
5 6 
7 8 
9 10 
 26 
 
3.2. Genomic DNA extraction, PCR amplification, 
cloning and sequencing 
To start the molecular screening of the ten strains, we performed the genomic DNA 
extraction for each strain. Then, the amplification of the 16S rRNA gene was made, using 
different primer pairs, 27F-1494R; 359F-1494R (Neilan et al., 1997; Jungblut et al.,2005). 
The amplification of the 16S rRNA gene, using these primers, resulted in amplicons with 
different size, since that with the 27F-1494R pair of primers all cyanobacteria strains 
presented a 1467 bp amplicon, as expected. In the same way, with the 359F-1494R all 
strains presented a 1135 bp amplicon. The organization of the results is performed 
according to the following numerical correspondence (1-10):  
Strain 1- LEGE 00233 
Strain 2- LEGE 00241 
Strain 3- LEGE 00243 
Strain 4- LEGE 00245 
Strain 5- LEGE 00246 
Strain 6- LEGE 00248 
Strain 7- LEGE 00250 
Strain 8- LEGE 00253 
Strain 9- LEGE 00259 
Strain 10- LEGE 04289 
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Figure 12- Amplification of the 16S rRNA gene with the primers 359F- 1494R(up);  27F- 
1494R  (down) for all ten strains. Samples: 3µl; 1kb plus DNA ladder: 1,5µl. 1,5% agarose 
gel; 1- LEGE 00233, 2- LEGE 00241, 3- LEGE 00243, 4- LEGE 00245, 5- LEGE 00246, 6- LEGE 
00248, 7- LEGE 00250, 8- LEGE 00253, 9-LEGE 00259, 10- 04289. 
All the strains showed amplicons of the expected size, using these sets of universal 
primers.  These results were consistent with the classification of the strains, as members 
of cyanobacteria group.   
These bands were excised and then the purified product was cloned into a pGEM-T 
vector, according with the protocol and method described above. The amplicons resulting 
from 27F-1494R was sent to sequencing but until the moment we haven’t obtained the 
sequencing results. The sequencing results of the amplicons resulting from the 359F-
1494R will provide more specific information about the strains, since the primers 359F is a 
cyanobacteria-specific primer. 
Following, we performed a screening for the genes involved in the cyanobactins 
production. In this work, was used a pair of primers, which were designed to amplify the 
gene encoding PatA protease, which cleaves the precursor peptide at the N-terminal 
recognition site (Lee et al., 2009). The primers amplified a 1.4 kb section of the patA gene. 
According with the Leikoski et al. study (2013), the patA gene is especially common in 
planktonic cyanobacteria. Furthermore, it’s also known that the cyanobactin pathway is 
1 2 3 4 5 6 7 8 9 10
1 2 3 4 5 6 7 8 9 10
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widespread and sporadically distributed in cyanobacteria and hinted at the potential 
chemical diversity of cyanobactins encoded in this pathway. 
These results were compared with the Anabaena sp.90, as a positive control (Leikoski et 
al., 2010). 
 
Figure 13- Amplification of the patA gene (1.4kb section) with the PatA pair of primers 
designed for this effect, by Leikoski et al. All the ten strains are represented. Tann = 52°C.  
Samples: 4µl; 10kb GeneRuler DNA ladder: 3µl. 0.7agarose gel. Positive control= Anabaena 
sp. 90. 
According with Figure 13, showing the electrophoresis results of the patA gene 
amplification, we can conclude that the strains with 1.4 kb amplicon were LEGE 00243, 
LEGE 00245, LEGE 00248 and LEGE 00259.   
We then proceeded to the amplification of the patE gene, using different pairs of 
primers (PreF/PreR and PreRNAR/PreRNAR).  
At this stage, we worked with only nine strains because one of them (LEGE 00250) 
showed a deficit of growth. Due to the lag in growth, this strain was not included in 
amplification of patE genes. We decided to increase the growth time and do the screening 
for this strain later. When the strain achieved the proper growth the amplifications of the 
patA genes was made and we verified that it did not result in an amplicon of the expected 
size (Figure 13).  
Regarding the patE genes, in the first screening the PreF/PreR pair of primers were 
used. The results were in accordance with the patA genes amplification, since we 
obtained positive result for the strains 3- LEGE 00243, 4-LEGE 00345, 6-LEGE 00248 
and 9-LEGE 00259. The exception on these results was the strains 8-LEGE 00253 and 
1 2 3 4 5 6 7 8 9 10 C+ C-
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10- LEGE 04289, which also presented band in the expected size. The results are shown 
in Figure 14 as an example.  
 
Figure 14- Amplification of patE genes, using primers PreR and PreF, from nine strains. 
Tann= 53ºC. Samples: 3µl ,1kb plus DNA ladder: 1.5µl. 1,5% agarose gel; 1- LEGE 00233, 2- 
LEGE 00241, 3- LEGE 00243, 4- LEGE 00245, 5- LEGE 00246, 6- LEGE 00248, 7- LEGE 00253, 
8- LEGE 00259, 9-LEGE 04289 
 
Figure 15- Amplification of the patE genes, using primers PreRNA R and PreRNA F, from 
nine strians. Tann=56ºC. Samples: 3µl, 1kb plus DNA ladder: 1.5µl. 1,5% agarose gel; 1- 
LEGE 00233, 2- LEGE 00241, 3- LEGE 00243, 4- LEGE 00245, 5- LEGE 00246, 6- LEGE 00248, 
7- LEGE 00253, 8- LEGE 00259, 9-LEGE 04289. 
Using the primers PreRNA R and PreRNA F we obtained one more strains with 
amplicon in the expected size (160 bp) comparing with the first primer pair used for patE 
gene amplification. This strain was 5- LEGE 00246. After, the excised bands were cloned 
and sent to sequencing 
With the precursor gene sequences in hand we proceeded to the in silico analysis. 
We aligned the sequence of the acy gene precursor for all strains with the acy gene 
percusor sequence of the Anabaena sp.90 (Figure 16). For this alignment, we used two 
1 2 3 4 5 6 8 97
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clones for each strain, each clone for a different set of primers, excluding the strain LEGE 
04289, which has only one clone and strain LEGE 00245 that has tree clones. This 
difference in the number of clones is because in the strain LEGE 04289 one of the 
sequenced clones was not in accordance with the expected (according to BLAST results), 
and in case of strain LEGE 00245 the patE gene screening result presented two bands of 
similar size. 
 
Figure 16- Alignment of the sequences of the acy precursor from all the strains with the acy 
precursor of the Anabaena sp. 90 (acyE). The areas of the precursor protein which form the 
mature cyanobactin are in grey 
The AcyE core peptide sequences allowed us to put forward putative structures of 
the anacyclamides found in the cyanobacterial strains, using the ChemDraw software. 
The anacyclamide with the amino acids sequence (Thr-Ser-Gln-Ile-Trp-Gly-Ser-Pro-
Val-Pro) was found in some of these strains and is already described in literature in 
several studies (Leikoski et al., 2010; Sivonen et al., 2010). It corresponds to 
anacyclamide A10 originally described from Anabaena sp. 90 (Figure 17). However, in 
four clones we obtained a different amino acids core sequence, which suggested that we 
could have a putative new anacyclamide. These four clones were from four different 
strains. Those are LEGE 00248, LEGE00253, LEGE 00259 and LEGE 04289.The new 
amino acids core sequence common between the first three strains, Ala-Asp-Asx-Glu-Tyr-
Gly-Tyr-Lys-Leu-Asp-Ala-Ser-Asp-Asx-Tyr-Ile-Pro, presents 17 amino acids. While the 
amino acids core sequence of LEGE 04289, Met-Leu-Cys-Asp-Ile-Gln-Thr-Arg-Glu-Cys-
Thr-Pro is smaller with 12 amino acids (Figure 18 and Figure 19). 
 
acy leader peptide, LEGE 00248 (R7P clone)     MTKKNIRPQQVAPVERETISTSKDQSGQITPSADNEYGYKLDASDNYIPFAGDDAE
acy leader peptide, Anabaena sp. 90  MTKKNIRPQQVAPVERETISTAKDQSGQVQAQTSQIWG---SP----VPFAGDDAE
acy leader peptide, LEGE 00243 (R1P clone)     MTKKNIRPQQVAPVERETISTAKDQSGQVQAQTSQIWG---SP----VPFAGDDAE
acy leader peptide, LEGE 00243 (Ra clone)  MTKKNIRPQQVAPVERETISTAKDQSGQVQAQTSQIWG---SP----VPFAGDDAE
acy leader peptide, LEGE 00246 (Rf clone)   MTKKNIRPQQVAPVERETISTAKDQSGQVQAQTSQIWG---SP----VPFAGDDAE
acy leader peptide, LEGE 00248 (Rg clone)   MTKKNIRPQQVAPVERETISTAKDQSGQVQAQTSQIWG---SP----VPFAGDDAE
acy leader peptide, LEGE 00253 (Ri clone) MTKKNIRPQQVAPVERETISTAKDQSGQVQAQTSQIWG---SP----VPFAGDDAE
acy leader peptide, LEGE 00245 (Rd clone)      MTKKNIRPQQVAPVERETISTAKDQSGQVQAQTSQIWG---SP----VPFAGDDAE
acy leader peptide, LEGE 00259 (R11P clone)   MTKKNIRPQQVAPVERETISTSKDQSGQITPSADNEYGYKLDASDNYIPFAGDDAE
acy leader peptide, LEGE 00253 (R9P clone) MTKKNIRPQQVAPVERETISTSKDQSGQITPSADNEYGYKLDASDNYIPFAGDDAE
acy leader peptide, LEGE 00259 (Rk clone)  MTKKNIRPQQVAPVERETISTAKDQSGQVQAQTSQIWG----SP----VPFAGDDAE
acy leader peptide, LEGE 04289 (R13P clone)    MTKKNIRPQQVAPVERETISTAKDRSGQVTALMLCDI------QTRECTPFAGDDAE
acy leader peptide, LEGE 00245 (R3P clone)   MTKKNIRPQQVAPVERETISTAKDQSGQVQAQTSQIWG---SP----VPFAGDDAE
acy leader peptide, LEGE 00245 (R5P clone) MTKKNIRPQQVAPVERETISTAKDQSGQVQAQTSQIWG---SP----VPFAGDDAE
1 10 20 30 40 50 56
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Figure 17- (A) AcyE peptide precursor from Anabaena sp. 90 with the hypervariable region 
of the 49-aminoacid protein encoding the mature anacyclamide shaded, indicating the 
position of cleavage and macrocyclization (grey). (B) Putative structure of the decapeptide 
anacyclamide A10 from Anabaena sp. 90 (Leikoski et al., 2010) 
In the same way, we designed the possible structure for the putative new anacyclamides 
based on these results.  
 
 
 
 
 
 
 
 
Percursor peptide AcyE from anabaena sp.90
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Figure 18- Putative structure of ADNEYGYKLDASDNYIP anacyclamide, using the sequence 
of AcyE precursor peptide from strain LEGE 00259 (example) 
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Percursor peptide AcyE from LEGE 00259
MTKKNIRPQQVAPVERETISTSKDQSGQITPS  ADNEYGYKLDASDNYIP  FAGDDAE
Molecular weight: 1930.0
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Figure 19- Putative structure MLCDIQTRECTP of anacyclamide, using the sequence of AcyE 
precursor peptide from strain LEGE 04289 (example) 
Based on these results some predictions regarding the linear mass, cyclic mass and post-
translational modifications were also made. All the predictions are presented in Table 5. 
Table 5- Anacyclamide predictions by each strain in study 
Strains 
Predictions 
R
e
fe
re
n
c
e
 
Core sequence 
A
m
in
o
 a
c
id
s
 
Linear 
mass 
(Da) 
Cyclic 
mass 
(Da) 
Post-translational 
modifications 
 
LEGE 00233 No predictions      
LEGE00241 No predictions      
LEGE00243 TSQIWGSPVP 10 1053.5   I. 
LEGE 00245 TSQIWGSPVP 10 1053.5   I. 
Percursor peptide AcyE from LEGE 04289
MTKKNIRPQQVAPVERETISTAKDRSGQVTAL  MLCDIQTRECTP  FAGDDAE
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Molecular weight: 1391.6
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LEGE 00246 TSQIWGSPVP 10 1053.5   I. 
LEGE 00248 
TSQIWGSPVP 10 1053.5   I. 
ADNEYGYKLDASDNYIP 17 1946.8 1928.8 
1996.8, 2064.8 
(monoprenyl, 
diprenyl 
 
LEGE 00250 No predictions      
LEGE 00253 
TSQIWGSPVP 10 1053.5   I. 
ADNEYGYKLDASDNYIP 17 1946.8 1928.8 
1996.8, 2064.8 
(monoprenyl, 
diprenyl 
 
LEGE 00259 
TSQIWGSPVP 10 1053.5   I. 
ADNEYGYKLDASDNYIP 17 1946.8 1928.8 
1996.8, 2064.8 
(monoprenyl, 
diprenyl 
 
LEGE 04289 MLCDIQTRECTP 12 1408.6 1390.6 
1350.6, 1312.6  
(thiazoles, 
thiazoles+oxazole
s) 
 
1388.6 (sulphur 
bridge) 
 
I.-This prediction is in accordance with data already published by Leikoski et al., 2010. 
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3.3. Chemical analysis 
We then sought to confirm our predictions by looking for the new cyanobactin-
related masses in the Anabaena cells. The methanol extracts of all strains were submitted 
to the LC-MS analysis as described. 
After the LC-MS analysis of all the strains, only the anacyclamide with the amino 
acids sequence ADNEYGYKLDASDNYIP was found, in its diprenylated form. This 
anacyclamide showed presence in two strains 6- LEGE 00248 and 9-LEGE 00259 (Table 
6), out of three candidates strains. 
In order to compare all the strains regarding the production of this or other 
prenylated anacyclamides, an analysis of the ten strains using a Neutral loss of 68 Da 
filter was performed (Figure 20). 
Table 6- Anacyclamides and their detection by LC-MS, in two Anabaena strains 
Strain Amino acid sequence [M+H]
+
 
Chemical 
formula Experimental 
mass 
Error 
(ppm) 
Diprenylated 
LEGE 
00248 
ADNEYGYKLDASDNYIP 2065,975 C96H136N20O31 2065.9839 4.16 
LEGE 
00259 
ADNEYGYKLDASDNYIP 2065,975 C96H136N20O31 2065.9792 1.88 
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LEGE 00259
LEGE 00248
 
Figure 20- Ion chromatograms of the ten Anabaena strains filtered for Neutral losses of 68 
Da. The two large clusters correspond to the two strains containing the diprenylated novel 
anacyclamide 
As seen in Figure 20, the strains LEGE 00259 and LEGE 00248 showed a peak with 
strong intensity compared with the other strains. This pick appeared in the chromatogram 
around the same retention time, in both strains. This fact is consistent with the 
anacyclamide production by both strains. 
The ADNEYGYKLDASDNYIP anacyclamide is present in two strains (LEGE 00248 
and LEGE 00259), as seen by LC-MS (Figures 21 and 22). The chromatograms show a 
peak with the retention time 19.0 min, with a mass spectrum containing a cluster with a 
[M+H]+ pseudomolecular ion at 2067 Da, indicating the presence of the predicted 
anacyclamide.  
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LC-MS analysis for the strain LEGE 00248 
 
Figure 21- MS profile TIC to the LEGE 00248 strain 
 
 
Figure 22- MS profile MS to the LEGE 00248 strain; Retention Time: 18,91min- 19,32min 
 
 
 
 
 
 
[M+H]
+
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LC-MS analysis for the strain LEGE 00259 
 
Figure 23- MS profile TIC to the LEGE 00259 strain 
 
Figure 24- MS profile MS to the LEGE 00259 strain; Retention Time: 18.93min-19.38min 
Comparing the LC-MS data with the predictions made, we conclude that the 
experimental mass of the putative new anacyclamide produced by strains LEGE 00248 
ans LEGE 00259 was bigger than the predicted mass by 136 Da. This fact is consistent 
with two prenylation sites.  
According with the literature, the known prenylated amino acids are tyrosine, serine, 
threonine, and tryptophan (Leikoski et al., 2010; Erickson et al., 2003). So, the probable 
prenylation sites in that anacyclamide is on Tyrosines (Tyr). However, in amino acids 
sequence the new anacyclamide presents three Tyrosines, so one of them probably didn’t 
presents prenylation and is unclear which tyrosines are prenylated. We have growth both 
strains in large-scale and performed a methanol extraction with the goal of purifying the 
new anacyclamides, as described in the material and methods. However, we have yet to 
perform the purification steps. Our objective is to perform 1D and 2D NMR experiments in 
the purified material to clarify the positioning of the prenyl groups, which should be 
achieved in conjunction with MS2 data.  
[M+H]
+
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In Table 7 we present the extraction yields for both strains 
Table 7- Extraction yields for LEGE 00248 and LEGE 00259 strains 
Strains Lyophilized mass Extract mass R 
LEGE 00248 1,29g 0,28g 21,7% 
LEGE00259 1,27g 0,28g 22,0% 
We have also strived to characterize the putative cyanobactin cluster in LEGE 
00259, which is responsible for the new anacyclamide production. Thus, the acy gene 
cluster was amplified, with patex2f (5’-ATGGATCCTGATGGACTGTAGTGTGAG-3’) and 
patex5r (5’-TACTCGAGAGGTTTTGGGACTCTTTAG-3’) primers in three 60-µl reaction, 
as described previously, and cloned in E.coli TOP10. The three clones obtained were sent 
to sequencing. This approach was supported in other works, for example in the work 
involving the Anabaena sp. 90 gene cluster sequencing (Leikoski et al., 2010). By this 
time, we have yet to obtain the sequencing results and perform the consequent analysis 
of the entire gene cluster from LEGE 00259 strain. 
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4. Conclusion and future work 
In this study we reported a novel low-molecular-weight peptide produced 
ribosomally by Anabaena strains. The new post-translationally modified anacyclamide, 
with two prenyl groups, was detected in two of ten Anabaena strains screened for. The 
probable prenylation sites are on Tyrosines. However the anacyclamide presented, in the 
amino acids sequence, three Tyrosines. It is unclear which Tyrosines are prenylated and 
further investigations on the prenylation mechanisms may help us gain more insight into 
these post-translational tailoring events, for example, the basis for the non-prenylation of 
one of the tyrosine side-chains. 
The next step will be to carry out nuclear magnetic resonance (NMR) to fully 
characterize this new compound, identifying in which Tyrosines the prenylation occurs to 
make a phylogenetic inference regarding anacyclamides production in these and other 
strains.  
Overall, this study reports a new cyanobacterial secondary metabolite, which can 
expand our knowledge about this family of compounds and their biological activity.  
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